Loading…
Employees: 8,347
Size Jyothy Labs (JYOTHYLAB.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $773M, the 683rd largest of 1,058 India companies the cockpit tracks. Shares closed at ₹198.69 on 6 Nov 2026.
Performance Over six months the shares fell 23.1%, against -9.2% for the median peer and 0.0% for the India market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 4.6% over the last twelve months (peer median +11.5%); the operating margin is 7.6% (peer median 9.8%).
Valuation It trades at 30.9× forward earnings against a peer median of 18.9× (5th most expensive of 20).
Price implies For today's price to make sense, revenue must grow about 35% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is +26 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.5 points below its cost of capital (19.0% WACC).
Next results Next results expected around 27 Jan 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹29.9B | ₹29.4B | ₹28.4B | ₹27.7B | ₹25.0B |
| Revenue growth | — | +4% | +3% | +11% | — |
| Gross profit | ₹8.18B | ₹9.45B | ₹10.00B | ₹9.62B | ₹7.02B |
| EBITDA | ₹2.91B | ₹4.58B | ₹5.06B | ₹4.95B | ₹3.31B |
| Net income | ₹2.07B | ₹3.33B | ₹3.71B | ₹3.69B | ₹2.40B |
| Free cash flow | n/a | ₹3.58B | ₹2.69B | ₹4.42B | ₹2.90B |
| Capital expenditure | n/a | ₹669M | ₹581M | ₹371M | ₹355M |
| Total debt | ₹611M | ₹516M | ₹613M | ₹506M | ₹465M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | JYOTHYLAB.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.8% | -10.4% | 4th highest of 21 |
| 6-month return | -23.1% | -9.2% | 7th lowest of 21 |
| Distance from 52-week high | -37.9% | -34.9% | 10th lowest of 21 |
| Revenue growth (TTM) | +4.6% | +11.5% | 7th lowest of 21 |
| Operating margin | 7.6% | 9.8% | 9th lowest of 21 |
| Forward P/E | 30.9× | 18.9× | 5th most expensive of 20 |
| Growth the price implies (Req g, 7 yrs) | 35.0% | 2.5% | most demanding of 16 |
| Growth delivered (Del g) | +8.9% | +8.2% | 8th highest of 16 |
| Hurdle (Req g minus delivered) | +26.1 pp | -6.4 pp | most demanding of 16 |
| ROIC minus cost of capital | -0.5 pp | +5.6 pp | 7th lowest of 21 |
| EV / EBITDA | 23.0× | 10.8× | 3rd most expensive of 13 |
| Net debt / EBITDA | -2.1× | -1.3× | 5th least indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jyothy Labs JYOTHYLAB.NS | India | $773M | -23% | +5% | 8% | 30.9× | 35.0% | +8.9% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $750M | -19% | +10% | 6% | 17.7× | 4.7% | +7.7% |
| Cosmecca Korea 241710.KS | South Korea | $798M | +25% | +44% | 13% | 14.4× | -5.9% | +13.6% |
| Galaxy Surfactants GALAXYSURF.NS | India | $819M | +13% | +30% | 9% | 18.6× | 18.0% | +13.7% |
| Milbon 4919.T | Japan | $669M | +30% | +6% | 13% | 22.9× | -3.1% | +8.2% |
| Runben Biotechnology 603193.SS | China | $940M | -33% | +13% | 21% | 18.9× | 1.7% | +28.4% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $944M | +15% | +10% | 11% | 28.9× | 4.3% | +10.8% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $961M | +47% | +54% | 7% | 54.0× | n/a | n/a |
| Noevir 4928.T | Japan | $977M | +3% | +1% | 16% | 19.4× | -4.8% | +4.5% |
| SYoung 300740.SZ | China | $1.00B | -37% | +14% | 3% | 39.6× | 18.1% | +6.1% |
| PZ Cussons PZC.L | United Kingdom | $566M | +30% | +5% | 11% | 13.3× | -1.7% | -2.1% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.06B | 0% | +74% | 18% | 12.1× | 11.5% | +49.0% |
| Bajaj Consumer Care BAJAJCON.NS | India | $551M | -24% | +29% | 22% | 19.6× | 14.6% | +5.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.22B | -52% | +23% | 8% | 15.0× | -5.9% | +21.2% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $464M | -25% | -7% | 4% | n/a | n/a | n/a |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $448M | -15% | -8% | 9% | 20.8× | 2.5% | +6.3% |
| Lafang China 603630.SS | China | $445M | -20% | -3% | 2% | 40.4× | n/a | n/a |
| Jinglv Environment Science & Technology 001230.SZ | China | $415M | -22% | +28% | 11% | 14.7× | n/a | n/a |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |